Subscribe to our Newsletters !!
Alcohol-based solvents and cleaning agents are pop
Biotech Fluidics offers a range of non-invasive fl
The recent rabies death of an 11 year old Canadian
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Micro
IOL Chemicals and Pharmaceuticals Limited (IOL), a leading manufacturer of pharmaceutical (APIs) and specialty chemicals, announced receiving EDQM certification to supply Pantoprazole Sodium Sesquihydrate API across European market. Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion.
The company started production of Pantoprazole Sodium Sesquihydrate in Q3 FY 2020 at its Punjab based facility. With this CEP certification, the Company will now be able to export it to entire Europe. IOL currently, has a total capacity of producing 240 TPA of Pantoprazole Sodium Sesquihydrate.
IOL is the world largest producer of Ibuprofen API with 33% market share globally. The Company has 13 plus APIs in its portfolio such as Metformin Hydrochloride, Clopidogrel Bisulfate Form II, Fenofibrate, Paracetamol etc
